Brain Imaging in Behavioral Neuroscience. 1st ed. 2012

種類:

電子ブック

責任表示:

edited by Cameron S. Carter, Jeffrey W. Dalley

出版情報:

Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2012

著者名:

• Carter, Cameron S.
• Dalley, Jeffrey W.
• SpringerLink (Online service)

シリーズ名:

Current Topics in Behavioral Neurosciences ; 11

ISBN:

9783642287114 [3642287115]    

注記:

From the contents -- Preface -- Food and drug reward: overlapping circuits in human obesity and addiction -- Nonhuman Primate Models of Addiction and PET Imaging: Dopamine System Dysregulation -- Neural and behavioral endophenotypes in ADHD -- Experimental protocols for behavioral imaging: Seeing animal models of drug abuse in a new light -- Molecular Imaging and the Neuropathologies of Parkinson’s disease -- Imaging of Seasonal Affective Disorder and Seasonality effects on serotonin and dopamine function in the Human Brain -- Magnetic resonance spectroscopic methods for the assessment of metabolic functions in the diseased brain -- MR Spectroscopic Studies of the Brain in Psychiatric Disorders -- fMRI As A Measure of Cognition Related Brain Circuitry In Schizophrenia -- MRI studies in Late-Life Mood Disorders -- The role of diffusion tensor imaging in the study of cognitive aging -- Structural, functional and spectroscopic MRI studies of Methamphetamine addiction -- Pharmacological MRI Approaches to Understa
This volume highlights the remarkable new developments in brain imaging, including those that apply magnetic resonance imaging (MRI) and Positron Emission Tomography (PET), that allow us to non invasively study the living human brain in health and in disease.  These technological advances have allowed us to obtain new and powerful insights into the structure and function of the healthy brain as it develops across the life cycle, as well as the molecular make up of brain systems and circuits as they develop and change with age.  New brain imaging technologies have also given us new insights into the causes of many common brain disorders, including ADHD, schizophrenia, depression and Alzheimer’s disease, which collectively affect a large segment of the population.  These new insights have major implications for understanding and treating these brain disorders, and are providing clinicians with the first ever set of biomarkers that can be used to guide diagnosis and monitor treatment effects. The advances in bra

ローカル注記:

学内専用E-BOOKS (local access only)